Kindlin-1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types.
Azorin P, Bonin F, Tariq Z, Petitalot A, Coussy F, Marangoni E, Becette V, Denoux Y, Vincent-Salomon A, Le Tourneau C, Larbi Cherif L, Klijanienko J, Kamal M, Bièche I, Lidereau R, Driouch K.
Azorin P, et al. Among authors: lidereau r.
Clin Transl Med. 2022 Apr;12(4):e813. doi: 10.1002/ctm2.813.
Clin Transl Med. 2022.
PMID: 35452191
Free PMC article.
No abstract available.